Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
| Autor: | Beigel, John H1 jbeigel@niaid.nih.gov, Bao, Yajing2, Beeler, Joy1, Manosuthi, Weerawat3, Slandzicki, Alex4, Dar, Sadia M5, Panuto, John6, Beasley, Richard L7, Perez-Patrigeon, Santiago8, Suwanpimolkul, Gompol9,10, Losso, Marcelo H11, McClure, Natalie12, Bozzolo, Dawn R13, Myers, Christopher14, JrHolley, H Preston1, Hoopes, Justin15, Lane, H Clifford16, Hughes, Michael D2, Davey, Richard T16, Holley, H Preston Jr1 (AUTHOR) |
|---|---|
| Zdroj: | Lancet Infectious Diseases. Dec2017, Vol. 17 Issue 12, p1255-1265. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|